[P66] ポスターセッション 66　乳腺（メタ）

[P66-8] SERENA-4: Phase III trial of AZD9833 + palbociclib versus anastrozole + palbo-ciclib, in ER+/HER2- advanced breast cancer

^○岩田 広治¹, Fabrice Andre², Seock-Ah Im³, Patrick Neven⁴, Richard D Baird⁵, Johannes Ettl⁶, Matthew P Goetz⁷, Erika Hamilton⁸, Zefei Jiang⁹, Anil Abraham Joy¹⁰, Vincent Haddad¹¹, Andrew Walding¹², Manuel Selvi Miralles¹², Cynthia Huang-Bartlett¹², Antonio Llombart-Cussac¹³ (1.愛知県がんセンター, 2.Institut Gustave Roussy, 3.Seoul National University Hospital, 4.Universitair Ziekenhuis, 5.Cancer Research UK Cambridge Centre, 6.Technical University of Munich, 7.Mayo Clinic, 8.Sarah Cannon Research Institute and Tennessee Oncology, 9.The Fifth Medical Centre of Chinese PLA General Hospital, 10.Department of Oncology, University of Alberta, Cross Cancer Institute, 11.Oncology Biometrics, AstraZeneca, 12.Late Development, Oncology R&D, AstraZeneca, 13.Hospital Arnau de Vilanova)